Sol-Gel Technologies Ltd.

NasdaqGM:SLGL Stok Raporu

Piyasa değeri: US$14.2m

Sol-Gel Technologies Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Sol-Gel Technologies has a total shareholder equity of $34.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $42.0M and $7.1M respectively.

Anahtar bilgiler

0%

Borç/özkaynak oranı

US$0

Borç

Faiz karşılama oranın/a
NakitUS$30.47m
EşitlikUS$34.90m
Toplam yükümlülüklerUS$7.10m
Toplam varlıklarUS$42.01m

Son finansal sağlık güncellemeleri

Recent updates

Will Sol-Gel Technologies (NASDAQ:SLGL) Spend Its Cash Wisely?

Feb 28
Will Sol-Gel Technologies (NASDAQ:SLGL) Spend Its Cash Wisely?

Here's Why We're Watching Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Situation

Nov 07
Here's Why We're Watching Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Situation

Companies Like Sol-Gel Technologies (NASDAQ:SLGL) Are In A Position To Invest In Growth

Jul 21
Companies Like Sol-Gel Technologies (NASDAQ:SLGL) Are In A Position To Invest In Growth

Sol-Gel Technologies GAAP EPS of $0.01 beats by $0.11, revenue of $3.5M misses by $1.11M

Aug 04

These Analysts Think Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Sales Are Under Threat

May 17
These Analysts Think Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Sales Are Under Threat

We Think That There Are Issues Underlying Sol-Gel Technologies' (NASDAQ:SLGL) Earnings

Apr 15
We Think That There Are Issues Underlying Sol-Gel Technologies' (NASDAQ:SLGL) Earnings

Downgrade: Here's How Analysts See Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Performing In The Near Term

Apr 05
Downgrade: Here's How Analysts See Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Performing In The Near Term

We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Afford To Drive Business Growth

Nov 23
We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Afford To Drive Business Growth

We Think Sol-Gel Technologies (NASDAQ:SLGL) Needs To Drive Business Growth Carefully

Aug 04
We Think Sol-Gel Technologies (NASDAQ:SLGL) Needs To Drive Business Growth Carefully

Here's Why Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) CEO May Deserve A Raise

Jul 01
Here's Why Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) CEO May Deserve A Raise

Sol-Gel says no FDA notification regarding its marketing application for EPSOLAY

Apr 27

Newsflash: Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Analysts Have Been Trimming Their Revenue Forecasts

Mar 05
Newsflash: Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Analysts Have Been Trimming Their Revenue Forecasts

We're Not Very Worried About Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Rate

Feb 02
We're Not Very Worried About Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Rate

What Type Of Returns Would Sol-Gel Technologies'(NASDAQ:SLGL) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Dec 29
What Type Of Returns Would Sol-Gel Technologies'(NASDAQ:SLGL) Shareholders Have Earned If They Purchased Their SharesYear Ago?

FDA accepts Sol-Gel application for Twyneo

Dec 07

Sol-Gel: Slow And Steady Topical Technology

Nov 19

These Analysts Think Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Sales Are Under Threat

Nov 18
These Analysts Think Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Sales Are Under Threat

Sol-Gel Technologies EPS beats by $0.09, beats on revenue

Nov 12

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: SLGL's short term assets ($38.3M) exceed its short term liabilities ($5.2M).

Uzun Vadeli Yükümlülükler: SLGL's short term assets ($38.3M) exceed its long term liabilities ($1.9M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: SLGL is debt free.

Borcun Azaltılması: SLGL had no debt 5 years ago.


Bilanço


Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: SLGL has sufficient cash runway for more than a year based on its current free cash flow.

Tahmini Nakit Akışı: SLGL has sufficient cash runway for 2.7 years if free cash flow continues to grow at historical rates of 13.8% each year.


Sağlıklı şirketleri keşfedin